Shao-Zheng Peng

Title: Innovations of Shao-Zheng Peng: Pioneering Quinoxaline Compounds

Introduction: Shao-Zheng Peng, an innovative inventor based in New Taipei, Taiwan, has made significant contributions to the field of biotechnology. With a total of four patents to his name, Peng is focused on developing compounds that have promising applications in treating various diseases linked to protein kinases.

Latest Patents: Among his latest patents, two stand out in their potential to address critical health issues. The first patent involves Quinoxaline compounds, which are characterized by a specific structure (formula I) that plays a crucial role in treating protein kinase-related diseases. These compounds demonstrate utility in the in vitro, in situ, and in vivo diagnosis, prevention, or treatment of disorders in mammalian cells. The second patent focuses on Quinoxaline compounds as type III receptor tyrosine kinase inhibitors. This invention presents a compound capable of inhibiting kinases linked to diseases such as cancers, autoimmune diseases, and bone resorptive conditions. Both patents underline Peng’s commitment to medical advancements that target challenging health issues.

Career Highlights: Shao-Zheng Peng's professional journey is marked by his association with the Development Center for Biotechnology, where he applies his expertise in the development of innovative biopharmaceutical solutions. His work in this prestigious institution highlights his role as a leading contributor to the field of biotechnology and pharmaceuticals.

Collaborations: In his efforts to advance scientific research, he collaborates with notable colleagues such as Chu-Bin Liao and Nan-Horng Lin. These partnerships enhance the scope of his research and contribute to the creation of groundbreaking therapeutic applications.

Conclusion: Shao-Zheng Peng exemplifies the spirit of innovation in biotechnology. Through his inventions of Quinoxaline compounds, he is poised to make a lasting impact on the treatment of diseases mediated by protein kinases. His work not only reflects his dedication to scientific advancement but also highlights the importance of collaboration in the journey toward medical breakthroughs.